December 30, 2006

Nuvo’s Arthritis Lotion Delayed by U.S. Regulators (Update1) (Bloomberg.com)

Dec. 29 (Bloomberg) — U.S. regulators delayed approval of an experimental Nuvo Research Inc. arthritis lotion based on the same method of relieving pain as Merck & Co.’s Vioxx, withdrawn two years ago because of a link to heart attacks and strokes.

Read full story

Filed under Arthritis News by drwinn

Permalink • Print • Comment

Trackback uri

http://www.blogsyouwanttoread.com/arthritis.blog/arthritis-news/196/Nuvo's-Arthritis-Lotion-Delayed-by-U.S.-Regulators-(Update1)-(Bloomberg.com)/trackback/

Leave a comment






Made with WordPress and a search engine optimized WordPress theme • Sky Gold skin by Denis de Bernardy